Strides Pharma Inc.: Drug Recall
Recall #D-0895-2023 · 06/26/2023
Class II: Risk
Recall Details
- Recall Number
- D-0895-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Strides Pharma Inc.
- Status
- Terminated
- Date Initiated
- 06/26/2023
- Location
- East Brunswick, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,700 HDPE Bottles
Reason for Recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Product Description
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
Distribution Pattern
Nationwide in the USA.
Other Recalls by Strides Pharma Inc.
- Class II: Risk 07/09/2025
- Class II: Risk 03/05/2025
- Class II: Risk 03/05/2025
- Class II: Risk 12/29/2023
- Class II: Risk 07/19/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.